多囊卵巢综合征中抗苗勒管激素的相关研究进展

Research progress of anti-Müllerian hormone in polycystic ovary syndrome

多囊卵巢综合征(PCOS)患者血清中抗苗勒管激素(AMH)水平较正常女性要高,其在PCOS发病机制中起了重要作用。近年来越来越多的研究提示,在PCOS诊断中AMH与卵巢多囊样改变有相似的诊断价值。同时,有不少研究发现AMH与PCOS的很多临床表现或生化指标存在相关性,并影响PCOS生育结局。本文就PCOS中AMH的相关研究及进展进行综述。

The serum level of anti-Müllerian hormone(AMH)in women with polycystic ovary syndrome(PCOS)is higher than that in normal women,which plays an important role in the pathogenesis of PCOS.In recent years,more and more studies have indicated that AMH and ovarian polycystic changes have similar diagnostic value in the diagnosis of PCOS.Many studies have found that AMH is correlated with the clinical manifestations or biochemical characteristics,and it may affect the fertility outcomes of PCOS.This paper reviews the related research and progress of AMH in PCOS.